G Jomrich1, B Jesch, P Birner, K Schwameis, M Paireder, R Asari, S F Schoppmann. 1. Gastroesophageal Cancer Unit, Department of Surgery, Upper-GI-Service, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Abstract
PURPOSE: Carbonic anhydrase IX (CA IX), a transmembrane glycoprotein, is known as an endogenous marker for hypoxia. Overexpressed in cancer-associated fibroblasts, CA IX has been reported to be associated with a poor outcome for a number of malignant tumors. Aim of this study was to investigate the role of CA IX in the tumor surrounding stroma of esophageal cancer. METHODS/PATIENTS: Stromal expression of CA IX in 361 formalin-fixed, paraffin-embedded specimens of invasive esophageal cancers, 206 adenocarcinoma (AC) and 155 squamous cell carcinoma (SCC), was investigated. RESULTS: In 42 cases (11.6 %), CA IX expression in the tumor surrounding stroma (AC 23 and SCC 19) was observed. Expression of CA IX correlated with the factors tumor stage (p < 0.001) and lymph node status (p = 0.008). Patients with CA IX expressed in the tumor surrounding stroma had a significant shorter disease-free survival (p = 0.007) and overall survival (p = 0.013). CONCLUSION: In esophageal cancer, CA IX-expressing tumor stroma is associated with shorter survival. Inhibition of the tyrosine kinase CA IX might represent a new onset for therapies against esophageal cancer.
PURPOSE:Carbonic anhydrase IX (CA IX), a transmembrane glycoprotein, is known as an endogenous marker for hypoxia. Overexpressed in cancer-associated fibroblasts, CA IX has been reported to be associated with a poor outcome for a number of malignant tumors. Aim of this study was to investigate the role of CA IX in the tumor surrounding stroma of esophageal cancer. METHODS/PATIENTS: Stromal expression of CA IX in 361 formalin-fixed, paraffin-embedded specimens of invasive esophageal cancers, 206 adenocarcinoma (AC) and 155 squamous cell carcinoma (SCC), was investigated. RESULTS: In 42 cases (11.6 %), CA IX expression in the tumor surrounding stroma (AC 23 and SCC 19) was observed. Expression of CA IX correlated with the factors tumor stage (p < 0.001) and lymph node status (p = 0.008). Patients with CA IX expressed in the tumor surrounding stroma had a significant shorter disease-free survival (p = 0.007) and overall survival (p = 0.013). CONCLUSION: In esophageal cancer, CA IX-expressing tumor stroma is associated with shorter survival. Inhibition of the tyrosine kinase CA IX might represent a new onset for therapies against esophageal cancer.
Authors: A Giatromanolaki; M I Koukourakis; E Sivridis; J Pastorek; C C Wykoff; K C Gatter; A L Harris Journal: Cancer Res Date: 2001-11-01 Impact factor: 12.701
Authors: S K Chia; C C Wykoff; P H Watson; C Han; R D Leek; J Pastorek; K C Gatter; P Ratcliffe; A L Harris Journal: J Clin Oncol Date: 2001-08-15 Impact factor: 44.544
Authors: Heikki Huhta; Olli Helminen; Sami Palomäki; Joonas H Kauppila; Juha Saarnio; Petri P Lehenkari; Tuomo J Karttunen Journal: Oncotarget Date: 2017-04-04
Authors: Eva A Ebbing; Amber P van der Zalm; Anne Steins; Aafke Creemers; Simone Hermsen; Rosa Rentenaar; Michelle Klein; Cynthia Waasdorp; Gerrit K J Hooijer; Sybren L Meijer; Kausilia K Krishnadath; Cornelis J A Punt; Mark I van Berge Henegouwen; Suzanne S Gisbertz; Otto M van Delden; Maarten C C M Hulshof; Jan Paul Medema; Hanneke W M van Laarhoven; Maarten F Bijlsma Journal: Proc Natl Acad Sci U S A Date: 2019-01-22 Impact factor: 11.205
Authors: Dimakatso Alice Senthebane; Tina Jonker; Arielle Rowe; Nicholas Ekow Thomford; Daniella Munro; Collet Dandara; Ambroise Wonkam; Dhirendra Govender; Bridget Calder; Nelson C Soares; Jonathan M Blackburn; M Iqbal Parker; Kevin Dzobo Journal: Int J Mol Sci Date: 2018-09-20 Impact factor: 5.923